A clinical study on the mechamism and early diagnosis of acute liver dysfunction following cardiac surgery.
心脏术后急性肝功能障碍发生机制及早期诊断的临床研究
基本信息
- 批准号:62570636
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1987
- 资助国家:日本
- 起止时间:1987 至 1988
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Acute liver dysfunction (ALD) is one of the major complications after cardiac surgery. To elucidate the mechanism of ALD following cardiac surgery and to establish useful predictor for ALD, we introduced hepatic venous oxygen saturation (ShvO_2) monitoring to the patients who underwent cardiac surgery.In 37 patients: 17 with congenital and 20 with acquired heart disease, ShvO_2 was measured for 1-4 days postoperatively. The mean ShvO_2 value for 24 hours around the lowest point (m-ShvO_2) was compared with the postoperative results of liver functions, hepatic lactate metabolism and hemodynamics. The results were as follows:1. m-ShvO_2 ranged from 5% to 79% with the average of 44%.2. In 14 patients with m-ShvO_2 <30%, 11 patients developed ALD with serum alanine aminotransferase (ALT) >100 U/l (the highest value: 4,050 U/l) or serum total bilirubin (TB)>3.0mg/dl (the highest: 11.5 mg/dl), and there were significant inverse correlations between m-ShvO_2 and the highest value of blood chemistry (ALT, GLDH, T-Bil). In 23 patients with m-ShvO_2>40%, the liver function indices stayed within almost normal ranges without significant correlations to m-ShvO_2.3. In 14 patients with m-ShvO_2 <30%, there was a significant inverse correlation between m-ShvO_2 and hepatic venous lactate pyruvate ratio.4. m-ShvO_2 showed significant relation to mixed venous oxygen saturation (SvO_2) and CVP in multivariate analysis.5. In pre, peri and postoperative factors, m-ShvO_2 most significantly contributed to ALD-score in multivariate analysis.In conclusion, significant decrease in ShvO_2 as below 30% appears to indicate hepatic tissue hypoxia causing ALD from hepatic hypoperfusion with resultant from systemic hypoperfusion and high CVP. And ShvO_2 monitoring may be useful to predict the development of ALD in critical patients after cardiac surgery.
急性肝功能障碍(ALD)是心脏手术后的主要并发症之一。为了阐明心脏手术后ALD的发生机制,建立预测ALD的有用指标,我们在心脏手术患者中引入肝静脉血氧饱和度(ShVO2)监测。37例患者,其中先天性心脏病17例,获得性心脏病20例。将最低点(m-ShVO2)前后24小时的ShVO2平均值与术后肝功能、肝乳酸代谢及血流动力学结果进行比较。结果表明:1.m-ShVO_2含量在5%~79%之间,平均为44%。14例m-ShVO2+30%患者中,11例ALD患者血清丙氨酸氨基转移酶(ALT)+GT;100U/L(最高值:4,050U/L)或总胆红素(TB)+GT;3.0 mg/dl(最高值:11.5 mg/dl),且m-ShVO2与血生化最高值(ALT、GLDH、T-Bil)呈显著负相关。23例m-ShVO_2和GT;40%的患者,肝功能指标基本在正常范围内,与m-ShVO_2无显著相关性。在14例m-ShVO_2+30%的患者中,m-ShVO_2与肝静脉乳酸丙酮酸比值呈显著负相关。多因素分析显示,m-ShVO_2与混合静脉血氧饱和度(SvO_2)、中心静脉压(CVP)显著相关。多因素分析显示,在术前、围手术期和术后,m-ShVO2对ALD评分的影响最为显著,ShVO2在30%以下时显著降低,提示肝组织缺氧是肝脏低灌流引起的,是全身低灌流和高CVP的结果。ShVO2监测可能有助于预测心脏手术后危重患者ALD的发展。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsuda, H.; Takano, H.; Nakano, S.; Shirakura, R.; Ohtani, M.; Taniguchi, K.; Miyamoto, Y., et al.: "Analysis of acute and chronic heart failure in view of hepatic oxygen supply-demand relationship using hepatic venous oxygen saturation." Japanese Circul
松田,H.;
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
高野弘志,松田暉,大谷正勝,谷口和博,大竹重彰,広瀬一,川島康生: 日本心臓血管外科学会雑紙. 17. 657-659 (1988)
Hiroshi Takano、Akira Matsuda、Masakatsu Otani、Kazuhiro Taniguchi、Shigeaki Otake、Hajime Hirose、Yasuo Kawashima:日本心血管外科杂志 17. 657-659 (1988)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takano, H.; Matsuda, H.; Ohtani, M.; Taniguchi, K.; Ohtake, S.; Hirose, H.; Kawashima, Y.: "A clinical study using hepatic vein catheterization on the mechanism for acute liver dysfunction following open heart surgery." Nippon Geka Gakkai Zasshi. 88. 1513
高野,H.;
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
松田暉,広瀬一,島崎靖久,谷口和博,西垣恭一,榊成彦,高野弘志,小川寛,妙中信之,川島康生: 日本胸部外科学会雑誌. 36. 1135-1141 (1988)
Akira Matsuda、Hajime Hirose、Yasuhisa Shimazaki、Kazuhiro Taniguchi、Kyoichi Nishigaki、Naruhiko Sakaki、Hiroshi Takano、Hiroshi Okawa、Nobuyuki Taenaka、Yasuo Kawashima:日本胸外科学会杂志。36. 1135-1141 (1988)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUDA Hikaru其他文献
MATSUDA Hikaru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUDA Hikaru', 18)}}的其他基金
Introduction of new strategy for end-stage heart failure by implantable ventricular assist device aiming to long-term-support with reintegration into society : Survey for the background and possible candidates.
通过植入式心室辅助装置引入治疗终末期心力衰竭的新策略,旨在为重新融入社会提供长期支持:调查背景和可能的候选人。
- 批准号:
21390396 - 财政年份:2009
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Myocardial regeneration therapy using nanotechnology enhances self-regeneration in damaged myocardium
使用纳米技术的心肌再生疗法可增强受损心肌的自我再生
- 批准号:
15209046 - 财政年份:2003
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
STUDIES FOR ESTABLISHMENT OF PEDIATRIC HEART AND LUNG TRANSPLANTATION IN JAPAN
日本开展儿科心肺移植的研究
- 批准号:
12307027 - 财政年份:2000
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Researches on novel techniques of organ-selective gene therapy in thoracic surgery
胸外科器官选择性基因治疗新技术研究
- 批准号:
11557100 - 财政年份:1999
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
MULTI-CENTER STUDIES FOR CLINICAL APPLICATION OF PEDIATRIC HEART AND LUNG TRANSPLANTATION IN JAPAN
日本小儿心肺移植临床应用多中心研究
- 批准号:
09307028 - 财政年份:1997
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A novel gene therapy for congestive heart failure.
一种治疗充血性心力衰竭的新型基因疗法。
- 批准号:
08557079 - 财政年份:1996
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A novel myocardial protection with in vivo gene transfection
体内基因转染的新型心肌保护
- 批准号:
06404047 - 财政年份:1994
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Research for natural prognosis and surgical effect in thoracic and abdominal aneurysm
胸腹动脉瘤自然预后及手术效果研究
- 批准号:
04557059 - 财政年份:1993
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Assessment of the myocardial protection in critical neonates
危重新生儿心肌保护作用的评估
- 批准号:
60480317 - 财政年份:1985
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
The effects of GLP-2 induced IGF-1 on intestinal failure-related liver dysfunction
GLP-2诱导IGF-1对肠衰竭相关肝功能障碍的影响
- 批准号:
23K08088 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rab4A Control of Liver Dysfunction in Mouse Models of Systemic Lupus Erythematosus.
Rab4A 对系统性红斑狼疮小鼠模型肝功能障碍的控制。
- 批准号:
10537786 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Rab4A Control of Liver Dysfunction in Mouse Models of Systemic Lupus Erythematosus.
Rab4A 对系统性红斑狼疮小鼠模型肝功能障碍的控制。
- 批准号:
10649477 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Novel coagulation-dependent mechanisms of liver regeneration to detect and prevent liver dysfunction after partial hepatectomy
肝脏再生的新型凝血依赖性机制可检测和预防部分肝切除术后的肝功能障碍
- 批准号:
10436916 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Novel coagulation-dependent mechanisms of liver regeneration to detect and prevent liver dysfunction after partial hepatectomy
肝脏再生的新型凝血依赖性机制可检测和预防部分肝切除术后的肝功能障碍
- 批准号:
10642950 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Novel coagulation-dependent mechanisms of liver regeneration to detect and prevent liver dysfunction after partial hepatectomy
肝脏再生的新型凝血依赖性机制可检测和预防部分肝切除术后的肝功能障碍
- 批准号:
10202588 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Novel biomarker for Fontan associated liver dysfunction and its interaction with Fontan specific hemodynamics
Fontan 相关肝功能障碍的新型生物标志物及其与 Fontan 特定血流动力学的相互作用
- 批准号:
20K08191 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of GATA1 mutation types on eosinophilia and liver dysfunction
GATA1突变类型对嗜酸性粒细胞增多和肝功能障碍的影响
- 批准号:
18K07810 - 财政年份:2018
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The investigation of specific maker for acute liver dysfunction by microRNA
microRNA对急性肝功能障碍特异性标志物的研究
- 批准号:
16K21413 - 财政年份:2016
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Effects of unhealthy eating behaviors on the inflammatory response and liver dysfunction in mice
不健康饮食行为对小鼠炎症反应及肝功能的影响
- 批准号:
15K07425 - 财政年份:2015
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)